Let’s Be Careful Out There

Let’s Be Careful Out There

The Sunday announcement by FDA Commissioner Dr. Stephen A Hahn that convalescent plasma has received emergency approval quickly sparked much controversy and serious concern in the medical community. While stating that the treatment reduced deaths by 35%, the data does...
Is it Safe to Reopen Schools?

Is it Safe to Reopen Schools?

Our country now faces the most significant public health crisis in more than a century. The COVID-19 virus has upended our lives and put all of us at risk for illness. As we approach the Fall, our thoughts turn to our children and their need to return to school. We...
Final Two Phases on the Road to Recovery

Final Two Phases on the Road to Recovery

In my first two articles on our road to recovery, I covered the first two phases of the COVID-19 pandemic. In them I shared my thoughts on how provider organizations could restart their service lines and expand their operations. Phase 3 of the pandemic is defined as...
Provider Road to Recovery: Phase 1

Provider Road to Recovery: Phase 1

The American Hospital Association estimates the lost revenue to hospitals from the pandemic to be $50.7 bil. per month or $202.6 bil. over the four-month period March 1 through June 30, 2020. Their estimates are based upon expected cancellations of patient services,...
The Choice

The Choice

The inherent nature of patient care requires making a choice. What therapy will help the patient get better? What is the probability the drug will cure the disease? What are the risks? Can the chemotherapy lead to injury or death? Both clinicians and their patients...